PROMMUNE LLC

Basic Information

4625 SO. 154TH CIR
OMAHA, NE, -

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Response-Selective C5a Agonist for the Treatment of Asthma

    Amount: $527,613.00

    DESCRIPTION (provided by applicant): An unmet need in the treatment of allergic asthma is an effective therapeutic strategy that focuses on an underlying cause of the disease rather than merely treat ...

    STTR Phase I 2011 Department of Health and Human Services
  2. A Peptide-Based Vaccine to Nicotine

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): The primary objective of this Phase I STTR project is to develop an effective, peptide-based nicotine vaccine for use in humans capable of inducing a robust, nicot ...

    STTR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government